Journal Article10.1016/J.JCIN.2021.06.041
ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical Trial.
Tiffany Patterson,Tim Clayton,Matthew Dodd,Zeeshan Khawaja,Marie Claude Morice,Karen Wilson,Won-Keun Kim,Nicolas Meneveau,Rainer Hambrecht,Jonathan Byrne,Didier Carrié,Doug Fraser,David H. Roberts,Sagar N. Doshi,Azfar Zaman,Adrian P. Banning,Hélène Eltchaninoff,Hervé Le Breton,David Smith,Ian Cox,Derk Frank,Anthony H. Gershlick,Mark A. de Belder,Martyn Thomas,David Hildick-Smith,Bernard Prendergast,Simon Redwood,Stuart J. Pocock,Duolao Wang,Florian Irague +29 more
148
TL;DR: In this article, percutaneous coronary intervention (PCI) prior to transcatheter aortic valve replacement (TAVR) in patients with significant coronary artery disease would produce non-inferior clinical results when compared with no PCI (control arm).
read more
Abstract: Objectives This study sought to determine if percutaneous coronary intervention (PCI) prior to transcatheter aortic valve replacement (TAVR) in patients with significant coronary artery disease would produce noninferior clinical results when compared with no PCI (control arm). Background PCI in patients undergoing TAVR is not without risk, and there are no randomized data to inform clinical practice. Methods Patients with severe symptomatic aortic stenosis and significant coronary artery disease with Canadian Cardiovascular Society class ≤2 angina were randomly assigned to receive PCI or no PCI prior to TAVR. The primary endpoint was a composite of all-cause death or rehospitalization at 1 year. Noninferiority testing (prespecified margin of 7.5%) was performed in the intention-to-treat population. Results At 17 centers, 235 patients underwent randomization. At 1 year, the primary composite endpoint occurred in 48 (41.5%) of the PCI arm and 47 (44.0%) of the no-PCI arm. The requirement for noninferiority was not met (difference: -2.5%; 1-sided upper 95% confidence limit: 8.5%; 1-sided noninferiority test P = 0.067). On analysis of the as-treated population, the difference was -3.7% (1-sided upper 95% confidence limit: 7.5%; P = 0.050). Mortality was 16 (13.4%) in the PCI arm and 14 (12.1%) in the no-PCI arm. At 1 year, there was no evidence of a difference in the rates of stroke, myocardial infarction, or acute kidney injury, with higher rates of any bleed in the PCI arm (P = 0.021). Conclusions Observed rates of death and rehospitalization at 1 year were similar between PCI and no PCI prior to TAVR; however, the noninferiority margin was not met, and PCI resulted in a higher incidence of bleeding. (Assessing the Effects of Stenting in Significant Coronary Artery Disease Prior to Transcatheter Aortic Valve Implantation; ISRCTN75836930 )
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Progress in the Application of the Residual SYNTAX Score and Its Derived Scores
Lin X,Zhibin Mei,Wei Ji,Yaoguo Wang,Chaoxiang Xu +4 more
TL;DR: The residual SYNTAX score and its derived scores are used for quantifying residual coronary lesions and guiding revascularization. They are combined with other examinations to assess the severity of vascular disease and play a guiding role in clinical practice.
Management of Coronary Artery Disease in Patients Referred for Transcatheter Aortic Valve Replacement
Aditya Mantha,Besir Besir,Grant Reed,James Yun,Rishi Puri,Amar Krishnaswamy,Samir Kapadia +6 more
- 01 Sep 2024
Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation
TL;DR: In this paper , the authors compared patients with either complete or incomplete myocardial revascularization were compared in a propensity score matched analysis, to take into account of baseline confounders.
Late Bleeding Events in Patients Undergoing Percutaneous Coronary Intervention in the Workup Pre-TAVR.
Marisa Avvedimento,Francisco Campelo-Parada,Erika Muñoz-García,Luis Nombela-Franco,Q. Fischer,Pierre Donaint,Vicenç Serra,Gabriela Veiga,Enrique Gutiérrez,Giovanni Esposito,Victoria Vilalta,Alberto Alperi,Ander Regueiro,Lluis Asmarats,Henrique Barbosa Ribeiro,Anthony Matta,Antonio J. Muñoz-García,Gabriela Tirado-Conte,Marina Urena,Damien Metz,Eduard Rodenas-Alesina,José M. de la Torre Hernández,Eduard Fernandez-Nofrerias,Isaac Pascual,Pablo Vidal-Calés,Dabit Arzamendi,Diego Carter Campanha-Borges,Kim-Hoang Trinh,Mélanie Côté,Laurent Faroux,Josep Rodés-Cabau +30 more
TL;DR: In T AVR candidates with concomitant significant coronary artery disease requiring percutaneous treatment, LBEs after TAVR were frequent and associated with increased mortality, and combining antiplatelet and anticoagulation regimens and the occurrence of periprocedural bleeding determined an increased risk of L BEs.
References
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Helmut Baumgartner,Volkmar Falk,Jeroen J. Bax,Michele De Bonis,Christian W. Hamm,Per Johan Holm,Bernard Iung,Patrizio Lancellotti,Emmanuel Lansac,Daniel Rodriguez Muñoz,Raphael Rosenhek,Johan Sjögren,Pilar Tornos Mas,Alec Vahanian,Thomas Walther,Olaf Wendler,Stephan Windecker,José Luis Zamorano +17 more
5.7K
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
Michael J. Mack,Martin B. Leon,Vinod H. Thourani,Raj Makkar,Susheel Kodali,Mark J. Russo,Samir R. Kapadia,S. Chris Malaisrie,David J. Cohen,Philippe Pibarot,Jonathon Leipsic,Rebecca T. Hahn,Philipp Blanke,Mathew R. Williams,James M. McCabe,David L. Brown,Vasilis Babaliaros,Scott M. Goldman,Wilson Y. Szeto,Philippe Généreux,Ashish Pershad,Stuart J. Pocock,Maria Alu,John G. Webb,Craig R. Smith +24 more
TL;DR: Among patients with severe aortic stenosis who were at low surgical risk, the rate of the composite of death, stroke, or rehospitalization at 1 year was significantly lower with TAVR than with surgery.
4.1K
The percutaneous coronary intervention prior to transcatheter aortic valve implantation (ACTIVATION) trial: study protocol for a randomized controlled trial
Muhammed Zeeshan Khawaja,Muhammed Zeeshan Khawaja,Duolao Wang,Stuart J. Pocock,Simon Redwood,Simon Redwood,Martyn Thomas +6 more
TL;DR: Using a definition of coronary artery disease severity closer to that used in everyday practice by interventional cardiologists will provide robust evidence to direct guidelines regarding TAVI therapy and improve its safety and efficacy profile of this developing technique.
Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry
Mohamed Abdel-Wahab,Ralf Zahn,Martin Horack,Ulrich Gerckens,Gerhard Schuler,Horst Sievert,Christoph Naber,Matthias Voehringer,Ulrich Schäfer,Jochen Senges,Gert Richardt +10 more
TL;DR: Its presence characterizes a high-risk population and is associated with increased crude short-term mortality, largely explained by co-morbidities, but does not limit functional improvement after TAVI.
92
TAVR Prognosis, Aging, and the Second TAVR Tsunami: Insights From France
TL;DR: The early results of the French national transcatheter aortic valve implantation registry, FRANCE 2 (FRench Aortic National CoreValve and Edwards registry), showed the need for safer and more effective technology to reduce the risk of adverse events.
26
Related Papers (5)
Arnav Kumar,Yasser Sammour,Shawn Reginauld,Kimi Sato,Nikhil Agrawal,Joo Myung Lee,Chandramohan Meenakshisundaram,Thammi Ramanan,Norihiko Kamioka,Abhishek C. Sawant,Divyanshu Mohananey,Patrick Gleason,Chandan Devireddy,Amar Krishnaswamy,Kreton Mavromatis,Kendra J. Grubb,Lars G. Svensson,E. Murat Tuzcu,Peter C. Block,Vijay Iyer,Vasilis Babaliaros,Samir R. Kapadia,Habib Samady +22 more
David A. Wood,John A. Cairns,Jia Wang,Roxana Mehran,Robert F. Storey,Helen Nguyen,Brandi Meeks,Vijay Kunadian,Jean-François Tanguay,Hahn-Ho Kim,Asim N. Cheema,Payam Dehghani,Madhu K. Natarajan,Sanjit S. Jolly,John Amerena,Matyas Keltai,Stefan James,Ota Hlinomaz,Kari Niemelä,Khalid F. AlHabib,Basil S. Lewis,Michel Nguyen,Jaydeep Sarma,Vladimir Dzavik,Anthony Della Siega,Shamir R. Mehta,Complete Investigators +26 more
Timo H. Mäkikallio,Niels Ramsing Holm,Mitchell Lindsay,Mark S. Spence,Andrejs Erglis,Ian B. A. Menown,Thor Trovik,Markku Eskola,Hannu Romppanen,Thomas Kellerth,Jan Ravkilde,Lisette Okkels Jensen,Gintaras Kalinauskas,Rikard Linder,Markku O. Pentikäinen,Anders Hervold,Adrian P. Banning,Azfar Zaman,Jamen Cotton,Erlend Eriksen,Sulev Margus,Henrik Toft Sørensen,Henrik Toft Sørensen,Per Hostrup Nielsen,Matti Niemelä,Kari Kervinen,Jens Flensted Lassen,Michael Maeng,Keith G. Oldroyd,Geoff Berg,Simon J Walsh,Colm G. Hanratty,Indulis Kumsars,Peteris Stradins,Terje K. Steigen,Ole Fröbert,Alastair N J Graham,Petter C Endresen,Matthias Corbascio,Olli A. Kajander,Uday Trivedi,Juha Hartikainen,Vesa Anttila,David Hildick-Smith,Leif Thuesen,Evald Høj Christiansen +45 more